DTIL

Precision BioSciences Inc

NASDAQ

Add Alert

DTIL

Precision BioSciences Inc

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

NY1972

04/21/24 12:06 AM

Post #300

Re: #299: @jondoeuk - Management can try and spin this as much

Why they hired a Chief People Officer instead of of trimming head count? another GNCA IMO

jondoeuk

04/16/24 6:07 PM

Post #299

Management can try and spin this as much as they want, but this is a failure https://www.businesswire.com/news/home/20240416117356/en/Precision-BioSciences-Announces-Return-of-Programs-and-Conclusion-of-Collaboration-with-Prevail-Therapeutics

Bearish

jondoeuk

04/06/24 4:05 PM

Post #298

Re: #288: @jondoeuk - Autoimmune diseases are clearly the next frontier for

If one of the companies that are developing off-the-shelf succeed, I don't see why any insurer will pay the price tag of an autologous therapy (assuming similar data/success). On paper, it should be easier than oncology.

Monksdream PremiumMember

03/11/24 3:01 PM

Post #297

DTIL 10Q due March 13

jondoeuk

03/02/24 10:57 PM

Post #296

Re: #295: @rtrstock - What do you mean an offering?

That didn't take long! https://www.businesswire.com/news/home/20240301968620/en/Precision-BioSciences-Announces-40.0-Million-Offering-of-Common-Stock-and-Warrants

Maybe things are going slower on the clinical front or no milestone payments are expected.

rtrstock

02/12/24 7:17 PM

Post #295

Re: #294: @surf1944 - Precision BioSciences, Inc. (DTIL) will effect a one-for-thirty

What do you mean an offering?

surf1944

02/12/24 5:44 PM

Post #294

Precision BioSciences, Inc. (DTIL) will effect a one-for-thirty (1-30) reverse split of its Common Stock. The reverse stock split will become effective on Wednesday, February 14, 2024. In conjunction with the reverse split, the CUSIP number will change to 74019P207

The 1 for 30 R/S will make it easy is come out with an offering in the next week or so.

Bearish

rtrstock

02/11/24 3:38 PM

Post #293

Re: #292: @jondoeuk - Now there will be one. The BOD approved

1 for 30 not bad, but still will have to hold a long time to get my money back, if I ever do, averaged in at maybe 1.30, so uncertain what price will need to be after reverse split eventually to even break even. Wanting to hold long and make money eventually, but unsure if that's still possible.

I have 5100 shares, so that will be cut to practically nothing, it'd have to go to nearly 50.00 a share for me to make my money back?

Is this correct? Is basically everyone even the big investors like Lilly and Cargill losing big on this one?

jondoeuk

02/09/24 6:38 PM

Post #292

Re: #291: @rtrstock - Guess I'll hold even if there is a R/S

Now there will be one. The BOD approved a 1-for-30 R/S. It will become effective at 5:00 p.m. ET on Feb 13. The uncertainty has been eliminated.

rtrstock

01/29/24 6:50 PM

Post #291

Re: #290: @jondoeuk - I thought they would, but it seems to

Guess I'll hold even if there is a R/S

jondoeuk

01/24/24 8:22 PM

Post #290

Re: #281: @rtrstock - What indication of a RS is there? Or

I thought they would, but it seems to me that they want to allow the clock to run before they set a R/S. Looking at the filing, it leaves the effective date to the BOD's discretion. It also gives the them the discretion to abandon it. The company has until the 22nd of April for the stock price to attain what is needed, thereby keeping its listing.

NY1972

01/20/24 8:56 PM

Post #289

Re: #288: @jondoeuk - Autoimmune diseases are clearly the next frontier for

Side dish becomes the main course. High paid bio CEOs need another bait and switch.

jondoeuk

01/19/24 9:35 PM

Post #288

Autoimmune diseases are clearly the next frontier for CAR-T/NK cell therapies, with numerous biotech and (big) pharma companies in the space https://finance.yahoo.com/news/precision-biosciences-completes-license-deal-120000510.html

81vette

01/09/24 3:12 PM

Post #287

Res. Breakout,after hours could get fun

81vette

01/09/24 1:10 PM

Post #286

Accumulation at nhod

81vette

01/09/24 1:09 PM

Post #285

Re: #284: @81vette - The 2.5m buy, should open some eyes

11th most newly watched ticker,do dd,others are wink

81vette

01/09/24 1:06 PM

Post #284

The 2.5m buy, should open some eyes

Bullish

81vette

01/09/24 11:49 AM

Post #283

Death hour is over,mid day vol surge coming,this pennant has gotten pointy/pokey/stabby(technical terms lol)held strong with .4333 last low bounce,demand growing now,waiting for thru .44 to send it higher

81vette

01/09/24 10:49 AM

Post #282

DTIL astronomical potential=greed/hold,tutes own 27%,insiders 21%,100M cash(no offerings),eps this year up 60%/sales past 5years up 102%(tells me sales have started and that explains tutes,I expect they buy more now) 27%below the sma200(so it’s got at least that much run room) target price 2.62, 198 employees,bullish chart since Oct 30th,could be some bashers because it is optionable/shortable,institutional could send this flying up,relative buying vol up 148Xs today ,shares available to short is dropping but still 3.5M(was 4.3m) overall I like that I can put this in my portfolio for long(or until chart breaks) and not have to watch it like a nail biting pump and dump,I have too many of those already lol

Bullish

rtrstock

12/01/23 12:23 PM

Post #281

Re: #278: @jondoeuk - Yes, but I think the R/S will happen.

What indication of a RS is there? Or is it assumed?

This looks like a good buy to me, am I wrong?

Bullish

NY1972

11/29/23 10:24 PM

Post #280

Re: #279: @NY1972 - This bio is walking dead. Failure to let

Plenty dead bios walking in this mkt. still handing out options like clock work.

NY1972

11/29/23 6:23 PM

Post #279

Re: #276: @jondoeuk - So, at 4:30pm the day before Thanksgiving, they

This bio is walking dead. Failure to let go the PhDs and CARTs a few years ago costed hundreds millions. ARCUS will be bought by IECure after the cash dries up.

jondoeuk

11/29/23 3:53 PM

Post #278

Re: #277: @Sirpeter - There's still time

Yes, but I think the R/S will happen.

Sirpeter

11/28/23 4:57 PM

Post #277

Re: #276: @jondoeuk - So, at 4:30pm the day before Thanksgiving, they

There's still time

jondoeuk

11/27/23 8:34 PM

Post #276

Re: #260: @jondoeuk - The market did not find the recent announcement

So, at 4:30pm the day before Thanksgiving, they announce a special meeting to vote on a R/S. It will take place on Thurs, Jan 18, '24, at 11:00 am, Eastern Time, at a ratio ranging from 1-for-10 and 1-for-30.

Bearish

Sirpeter

11/20/23 10:44 AM

Post #275

Re: #274: @knrorrel - nice chart, bottom now and here, Now get

Moving up nicely...looks good

knrorrel

11/07/23 8:17 AM

Post #274

Re: #271: @rtrstock - Well on stock twits they are saying there

nice chart, bottom now and here, Now get the news out and let's see what happens, maybe we'll almost never see these low prices down here on the ground again.
imho

knrorrel

11/07/23 8:15 AM

Post #273

Re: #271: @rtrstock - Well on stock twits they are saying there

News Out, should running hard in good News
imho

knrorrel

11/07/23 8:14 AM

Post #272

Re: #269: @Monksdream - DTIL new 52 week low https://investorshub.advfn.com/uimage/uploads/2023/10/

a really nice $DTIL News https://ih.advfn.com/stock-market/NASDAQ/precision-biosciences-DTIL/stock-news/92484281/precision-biosciences-reports-third-quarter-2023-f

rtrstock

10/16/23 12:30 PM

Post #271

Re: #270: @konshe - bottom rebound coming, time to buy.

Well on stock twits they are saying there is no filed reverse split and that they are expecting an extension to be filed, so I hope you are right. I'm uncertain what all is going on, but I like what this company is doing with it's aspirations in medicine, so staying with it. Just accumulated more, lowered my average cost.

Bullish

konshe

10/13/23 11:02 AM

Post #270

Re: #268: @Monksdream - DTIL new 52 week low https://investorshub.advfn.com/uimage/uploads/2023/9/2

bottom rebound coming, time to buy.

Bullish

Monksdream PremiumMember

10/02/23 3:56 PM

Post #269

DTIL new 52 week low

Monksdream PremiumMember

09/29/23 1:38 PM

Post #268

DTIL new 52 week low

Monksdream PremiumMember

09/23/23 3:41 PM

Post #267

DTIL new 52 wewek low

NY1972

09/17/23 1:26 AM

Post #266

Re: #264: @jondoeuk - Or it could end up like TRIL. ARCUS

DTIL founders never worried about cash until the meltdown. They hired too many PhDs, built fancy expensive labs with lots of promises. They never tried to trim the expenses to make sure there will be cash left for clinical trials. High burn and lots of GT bios spell doom for this bio.

jondoeuk

09/14/23 5:42 PM

Post #265

Re: #264: @jondoeuk - Or it could end up like TRIL. ARCUS

I should have pointed out that companies are happening to develop small[er] nucleases. Here is one paper from Casebia Therapeutics, which is a joint venture between CRSP and BAYN https://www.nature.com/articles/s41467-021-24454-5

Also, in 2020, researchers led by Dr. Liu created a new base editor that could perform C-to-T conversion of DNA in mitochondria. However, it had limitations, not only being restricted to that conversion, but mostly limited a certain motif. This means that it could correct only 10% of confirmed pathogenic mitochondrial point mutations https://www.nature.com/articles/s41587-022-01256-8

Last year another novel base editor was created that could achieve A-to-G conversion. Being able to perform that could correct 43% of confirmed pathogenic mitochondrial point mutations https://www.cell.com/cell/fulltext/S0092-8674(22)00389-0

However, I don't see either base editor entering the clinic for a number of years.

jondoeuk

09/13/23 6:38 PM

Post #264

Re: #263: @NY1972 - IECure will buy the ARCUS IP when cash

Or it could end up like TRIL. ARCUS has some benefits over current CRISPR systems, manly its size, can edit the mitochondrial genome and IP is not a mess.

NY1972

09/07/23 10:33 PM

Post #263

Re: #262: @jondoeuk - Not the most productive use of its cash

IECure will buy the ARCUS IP when cash is 0 in 18 months.

jondoeuk

09/07/23 6:06 PM

Post #262

Re: #261: @NY1972 - this is a homeless shelter for PhDs. Cash

Not the most productive use of its cash so far. The R&D Day could change that, but the market doesn't seem to think it.

NY1972

08/31/23 3:07 PM

Post #261

Re: #260: @jondoeuk - The market did not find the recent announcement

this is a homeless shelter for PhDs. Cash is not spent on patients. They hired a chief people officer to cut the pie.

jondoeuk

08/28/23 6:14 PM

Post #260

Re: #252: @rtrstock - Well I hope sofmething works out, I'm all

The market did not find the recent announcement attractive https://www.businesswire.com/news/home/20230815091930/en/Precision-BioSciences-Completes-Strategic-Transaction-with-Imugene-for-Azer-Cel-in-Cancer

I think a reverse split is a possibility, especially after the announcement couldn't move the PPS. If that happens, will likely add fuel to any downward price pressure. Management don't seem the best. Now it's do or die with the in vivo programs.

rtrstock

08/24/23 7:35 PM

Post #259

Re: #258: @J-mak - In my opinon slim very very slim

That's what I'm afraid of, guess I'll just wait. Keep my shares.

J-mak

08/24/23 1:39 PM

Post #258

Re: #257: @rtrstock - What's the educated guess?

In my opinon slim very very slim

rtrstock

08/23/23 3:57 PM

Post #257

What's the educated guess?

What's realistically possible by October date for pps to be more than $1.00

J-mak

08/17/23 5:48 PM

Post #256

Re: #255: @Monksdream - DTIL new 52 week low

Didn't you already say that

Monksdream PremiumMember

08/17/23 2:21 PM

Post #255

DTIL new 52 week low

rtrstock

08/17/23 7:47 AM

Post #254

$227 Million in Upfront Economics and Milestone Payments for Azer-Cel in Addition to Double-Digit Royalties on Sales
Imugene
https://www.businesswire.com/news/home/20230815091930/en/Precision-BioSciences-Completes-Strategic-Transaction-with-Imugene-for-Azer-Cel-in-Cancer

Monksdream PremiumMember

08/16/23 1:55 PM

Post #253

DTIL new 52 week low

rtrstock

08/03/23 10:42 PM

Post #252

Re: #251: @jondoeuk - Notice of delisting was on the 28th of

Well I hope sofmething works out, I'm all in on this one , and have been steadily accumulating shares.
If I recall correctly, Moderna pps was high for years before they ever had an approval for a product.
I see so much potential for this company I'm putting everything I have on it. Will see what happens.

jondoeuk

07/29/23 2:45 PM

Post #251

Re: #249: @rtrstock - Hope this doesn't delist?

Notice of delisting was on the 28th of April. This gives them a 180-day period to regain compliance ($1.00 for a minimum of ten consecutive business days). If not, they could file for an extension.